"We believe that any patient with severe asthma will want this device at home. This is the glucometer for asthmatics."
— Rich Lotti, president/CEO of Aperion, "FDA clears Apieron's Insight to personalize asthma therapy," pp. 1, 6.
Subscribe to BioWorld™ news services
"We believe that any patient with severe asthma will want this device at home. This is the glucometer for asthmatics."
— Rich Lotti, president/CEO of Aperion, "FDA clears Apieron's Insight to personalize asthma therapy," pp. 1, 6.